Abstract:Pulmonary neuroendocrine tumors (PNETs) can be classified as four variants: typical carcinoid (TC), atypical carcinoid (AC), small cell lung cancer (SCLC) and large cell neuroendocrine carcinoma (LCNEC). Classification of the four tumor categories is a step-wise process identified by the presence of necrosis and number of mitoses per 2mm2. In NE tumor pathology, Ki-67 was first described as prognostic factor in the pancreas and was incorporated into the grading system of digestive tract NE neoplasms in the 2010 World Health Organization (WHO) classification. However, the significance of Ki-67 has not been fully studied in PNETs. The purpose of our research is to investigate the potentially diagnostic value of Ki-67. We retrieved 160 surgical specimens of pulmonary neuroendocrine tumors (37 TC, 2 AC, 30 LCNEC, 91 SCLC) based on mitotic rate and histologic features. A nuclear quantitation algorithm was used to calculate the Ki-67 proliferative index (PI). Six equivalent fields (500 × 500μｍ) at 10× magnification were manually annotated for digital image analysis. The mitotic activity was manually quantitated in the most cellular areas on whole-slide images, eight 40× high power fields were calibrated as 2 mm2. The median mitotic count and Ki-67 index for TC, AC, LCNEC, and SCLC were 1 and 3.96%, 6 and 28.91%, 58 and 57.62%, 118 and 79.3%, respectively. However, the Ki-67 index overlapped among the four groups, with ranges of 0.38-13.49% for TC, 16.34-41.48% for AC, 30.67-93.74% for LCNEC, and 12.43-96.87% for SCLC. The Ki-67 index was positively associated with mitotic number (P<0.001). Neuroendocrine carcinomas can be separated into two groups, high grade (Ki-67＞10％) and low grade (Ki-67≤10％). However, there is no adequate threshold to separate pulmonary AC from TC and no statistic difference of Ki-67 index between LCNEC and SCLC. For the univariate survival analyses in PNETs, both the Overall Survival (OS) and Progression Free Survival (PFS) correlated with Ki-67 index, mitotic number and nodal metastasis. But none of them was proved to be an independent prognostic factor. In high grade PNETs, multivariate analysis revealed that tumor size has a trend of being an independent prognostic factor, but did not reach significant level (P=0.085). Our results indicate that software-automated quantitation of Ki-67 index is a reliable method to predict the prognosis of PNETs. In addition, Ki-67 index can be a useful adjunct to pathologic grade in pulmonary neuroendocrine carcinoma.

Utility of Ki67 immunostaining in the grading of pineal parenchymal tumours: a multicentre study

How Reliable is the Ki-67 Cytological Index in Grading Pancreatic Neuroendocrine Tumors? A Meta-Analysis

Prognostic role of Ki-67 in glioblastomas excluding contribution from non-neoplastic cells

PUB034 Automated Quantification of Ki-67 Index Associates with Pathologic Grade and Prognosis of Pulmonary Neuroendocrine Tumors

Pineal Parenchymal Tumours: Minimum Apparent Diffusion Coefficient in Prediction of Tumour Grading

Automated Quantification Of Ki-67 Index Associates With Pathologic Grade Of Pulmonary Neuroendocrine Tumors

Significance of Staining Intensity in Ki-67 Proliferation Index in Meningiomas, and a Critical Review of the Literature on Proliferation Index Assessment

Survival and Malignant Transformation of Pineal Parenchymal Tumors: A 30-Year Retrospective Analysis in a Single-Institution

Role of Ki-67 proliferation index in the assessment of patients with neuroendocrine neoplasias regarding the stage of disease

Monocentric evaluation of Ki-67 labeling index in combination with a modified RPA score as a prognostic factor for survival in IDH-wildtype glioblastoma patients treated with radiochemotherapy

An In-Depth Exploration from Pathology to Adjuvant Therapies

Ki-67 Proliferation Index Is Associated With Tumor Grade and Survival in Pleural Epithelioid Mesotheliomas

Prediction of Higher Ki-67 Index in Pituitary Adenomas by Pre- and Intra-Operative Clinical Characteristics

Assessment of Ki67 expression for breast cancer subtype classification and prognosis in the Nurses’ Health Study

Clinicopathologic analysis of pineal parenchymal tumors of intermediate differentiation: a multi-institutional cohort study by the Kyushu Neuro-Oncology Study Group

Prognostic value of Ki-67 index in adult medulloblastoma after accounting for molecular subgroup: a retrospective clinical and molecular analysis

Modified Histopathological Grading Optimizes Prediction of Survival Outcomes in Small Intestinal Neuroendocrine Tumours

Preoperative CT Histogram Analysis to Predict the Expression of Ki-67 in Solid Pseudopapillary Tumours of the Pancreas.

A comprehensive correlation of the KI-67 proliferation index to patient ́s, imaging and tumor features and its value in predicting long-term course of patients with newly diagnosed intracranial meningiomas

Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms

Diagnostic, Prognostic, and Predictive Role of Ki67 Proliferative Index in Neuroendocrine and Endocrine Neoplasms: Past, Present, and Future